Tirzepatide Monotherapy Explored for Type 2 Diabetes in Chinese Participants
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Abstract
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Tirzepatide Monotherapy Compared With Placebo in Chinese Participants With Type 2 Diabetes
NCT ID: NCT05963022
Status: COMPLETED
Sponsor: Eli Li…